A sun-care essential in formats for all skin types
A wave of skincare launches from The Ordinary, Renew+Me, L’Oréal Paris and Biafine are expanding access to advanced actives, with prescription-strength options entering consumer channels and French pharmacy staples finding U.S. shelves. Readers are guided through the latest launches, prices and how they fit into daily routines.
The FDA has approved bemotrizinol (BEMT) for over‑the‑counter sunscreens, marking a modernization in U.S. UV protection. The ingredient absorbs both UVA and UVB rays, is photostable, and will debut as Parsol Shield before broader market adoption after an 18‑month exclusivity period. Industry and dermatology experts say the move could improve protection and user experience, though rollout and formulation timelines remain.
Five or more sunburns raise melanoma risk by up to 80%, with age and burn severity shaping outcomes. Experts urge daily sunscreen and preventive care as cases rise across the United States.
Independent and New York Post articles highlight Dr. Sebagh’s Exo C Booster and injectable exosome treatments, signaling a push to combine in-clinic regeneration with at-home skincare. Early user feedback notes immediate radiance and skin-plumping effects, while critics question long-term efficacy.
A round-up of recent cancer-related reports shows patients benefiting from clinical trials and rare misdiagnoses being corrected. From rectal cancer trials in the UK to cervical cancer misdiagnoses under review, readers are kept informed on treatment advances and patient experiences.
July retail activity across the UK shows mixed momentum. Food and hospitality have benefited from warm weather and England’s World Cup run, while non-food and big-ticket categories lag. Card spending is higher than a year ago, and consumer demand remains fragile as inflation and costs weigh on shoppers.